Current developments in early diagnosis of acute kidney injury
- 15 May 2013
- journal article
- review article
- Published by Springer Nature in International Urology and Nephrology
- Vol. 46 (1) , 1-7
Abstract
Acute kidney injury (AKI) is a very frequent and serious clinical problem, accounting for overall high morbidity and mortality. Up to date, mortality due to AKI is virtually unchanged over the past 50 years. This may partly be explained due to a delay in initiating renal protective and appropriate therapeutic measures since until now there are no reliable early-detecting biomarkers. The gold standard, serum creatinine, displays poor specificity and sensitivity with regard to identification of the incipient phase of AKI, and this is also true for cystatin C. We aimed to review novel biomarkers of AKI in urine and serum which have now progressed to the clinical phase. The main focus refers to their diagnostic and prognostic value. For this purpose, a web-based literature search using PubMed was performed comprising the following terms: renal failure, acute kidney injury and biomarkers. New molecules such as neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), N-acetyl-β-d-glucosaminidase (NAG), monocyte chemotactic peptide (MCP-1), Il-18, liver-type fatty acid-binding protein (L-FABP) and Netrin-1 are available and represent promising new markers that, however, need to be further evaluated in the clinical setting for suitability. In clinical settings with incipient AKI, not only the development and the implementation of more sensitive, practicable and accurate biomarkers are required for well-timed treatment initiation. Just as important is a substantial improvement of refined and applicable prophylactic therapeutic options in these situations. Before full adoption in clinical practice can be accomplished, adequately powered clinical trials testing a row of biomarkers are strongly warranted.Keywords
This publication has 43 references indexed in Scilit:
- Some biomarkers of acute kidney injury are increased in pre-renal acute injuryKidney International, 2012
- Urinary Vascular Cell Adhesion Molecule, But Not Neutrophil Gelatinase-associated Lipocalin, Is Associated with Lupus NephritisThe Journal of Rheumatology, 2012
- Urinary liver‐type fatty acid‐binding protein level as a predictive biomarker of contrast‐induced acute kidney injuryEuropean Journal of Clinical Investigation, 2011
- MCP-1 Gene Activation Marks Acute Kidney InjuryJournal of the American Society of Nephrology, 2011
- Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injuryKidney International, 2010
- Urinary Netrin-1 Is an Early Predictive Biomarker of Acute Kidney Injury after Cardiac SurgeryClinical Journal of the American Society of Nephrology, 2010
- Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injuryCritical Care, 2007
- Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized PatientsJournal of the American Society of Nephrology, 2005
- Differential gene expression following early renal ischemia/reperfusionKidney International, 2003
- Hospital-acquired renal insufficiencyAmerican Journal of Kidney Diseases, 2002